GENE WRITER

Serial Number 90071481
606

Registration Progress

Application Filed
Jul 24, 2020
Under Examination
Jun 22, 2021
Approved for Publication
Apr 27, 2021
Published for Opposition
Apr 27, 2021
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: GENE WRITER
Previous Owner: Tessera Therapeutics, Inc.
Classes: 001, 005, 042

Trademark Image

GENE WRITER

Basic Information

Serial Number
90071481
Filing Date
July 24, 2020
Published for Opposition
April 27, 2021
Abandonment Date
July 29, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 29, 2024
Classes
001 005 042

Rights Holder

Tessera Therapeutics, Inc.

03
Address
101 South Street, Suite 300
Somerville, MA 02143

Ownership History

Tessera Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Tessera Therapeutics, Inc.

Owner at Publication
03
Somerville, MA

Legal Representation

Attorney
Christina M. Licursi

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

42 events
Date Code Type Description Documents
Jul 29, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 29, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 19, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 18, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 22, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 16, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 22, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 23, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 21, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 21, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 21, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 6, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 6, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 6, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 22, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 20, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 20, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 20, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 2, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 24, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 22, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 22, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 22, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 9, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 5, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 5, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 5, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 22, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 27, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 27, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 7, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 19, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 15, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 15, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 15, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 12, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 12, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 12, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 10, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 23, 2020 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Aug 23, 2020 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Aug 21, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 001
Chemical and biological agents for scientific and research use, namely, for manipulating or modifying DNA
Class 005
Reagents for medical use, namely, molecular and cellular biology reagents and assays for the modification of cells and DNA; pharmaceutical preparations and therapeutic agents, namely, for gene therapy and DNA editing; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene, genome, and cellular editing, modulation, and modification for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals
Class 042
Research and development in the field of technology and engineering for the modification of DNA; development of new technology for others for enabling the engineering and modification of DNA, namely, developing molecular and cellular biology reagents, techniques, and assays for the modification of cells and DNA

Classification

International Classes
001 005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"GENE"